Zimmer Biomet's focus on expanding its product portfolio and improving cash flow suggests a positive outlook for long-term profitability. The company's undervaluation compared to peers and growth potential from innovation, acquisitions, and operational efficiency improvements are likely to positively impact its stock price in the short term.